Published in J Immunol Methods on February 10, 1988
IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. Nature (2014) 2.12
Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect Immun (1995) 1.08
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04
Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells. Virology (2006) 0.92
Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model. J Virol (2002) 0.91
In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants. J Clin Invest (1994) 0.90
Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A. J Virol (2008) 0.85
Murine monoclonal antibodies to DNA. A comparison of MRL/lpr NZB/W and chronically graft-versus-host-diseased mice. Clin Exp Immunol (1990) 0.78
Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro. Clin Exp Immunol (1995) 0.77
Production of hybridoma growth factor by human monocytes. Eur J Immunol (1987) 7.99
Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci (1975) 5.23
Increased plasma levels of interleukin-6 in sepsis. Blood (1989) 3.92
Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol (1988) 3.51
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med (1995) 2.98
Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes. J Immunol (1979) 2.79
Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol (1988) 2.63
Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol (1987) 2.59
Serum levels of interleukin-6 and acute phase responses. Lancet (1987) 2.44
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood (1990) 2.33
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity (2002) 2.31
Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol (1988) 2.24
Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum (1979) 2.23
Regulatory properties of LFA-1 alpha and beta chains in human T-lymphocyte activation. Nature (1988) 2.09
On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest (1992) 2.04
The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A. J Immunol (1979) 1.95
Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. J Biol Chem (1991) 1.92
Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun (1992) 1.85
A growth-factor dependent B-cell hybridoma. Curr Top Microbiol Immunol (1986) 1.79
The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun (1988) 1.76
An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun (1999) 1.75
Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol (1996) 1.74
Immunology of DNA. IV. Quantitative aspects of the Farr assay. J Immunol Methods (1976) 1.66
Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun (1989) 1.64
Immunology of DNA. I. The influence of reaction conditions on the Farr assay as used for the detection of anti-ds DNA. J Immunol Methods (1976) 1.63
Role of cytokines in sepsis. Adv Immunol (1997) 1.60
Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochim Biophys Acta (1991) 1.38
Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis (1982) 1.35
Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies. Eur J Immunol (1988) 1.34
Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis. Ann Rheum Dis (2006) 1.34
Detection of antibodies to DNA by radioimmunoassay and immunofluorescence. Scand J Rheumatol Suppl (1975) 1.30
Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems. Eur J Immunol (1987) 1.27
Development of a human interleukin-6 receptor antagonist. J Biol Chem (1994) 1.25
Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants. J Immunol (1990) 1.25
Induction of immunoglobulin synthesis by interleukin 2 is T4+/T8- cell dependent. A role for interleukin 2 in the pokeweed mitogen-driven system. Eur J Immunol (1985) 1.24
IL-6 is an intermediate in IL-1-induced thymocyte proliferation. J Immunol (1989) 1.23
Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol (1988) 1.22
Histone and DNA detection in swollen spermatozoa and somatic cells, by immunofluorescence. Clin Exp Immunol (1976) 1.21
Detection of anti-dsDNA as diagnostic tool. Ann Rheum Dis (1981) 1.21
Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.20
Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol (1997) 1.20
Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest (1998) 1.20
Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood (1991) 1.19
Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol (2007) 1.18
Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood (1992) 1.17
N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J (1997) 1.15
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer. Cancer Immunol Immunother (1992) 1.15
Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology (1989) 1.15
Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery (1991) 1.14
Chromatin-independent binding of serum amyloid P component to apoptotic cells. J Immunol (2001) 1.14
Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery (1993) 1.13
Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. Blood (1996) 1.12
Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus. Ann Rheum Dis (2003) 1.11
A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood (1989) 1.09
Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants. J Immunol (1989) 1.08
Dissociation of DNA/anti-DNA complexes at high pH. Immunol Commun (1980) 1.07
High IL-13 production by human neonatal T cells: neonate immune system regulator? Eur J Immunol (2001) 1.07
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 1.05
Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study. Br J Haematol (1998) 1.05
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation. Ann Rheum Dis (2009) 1.04
The first international standard for antibodies to double stranded DNA. Ann Rheum Dis (1988) 1.01
Analysis of human IL-6 mutants expressed in Escherichia coli. Biologic activities are not affected by deletion of amino acids 1-28. J Immunol (1989) 1.01
Clusterin: a protective mediator for ischemic cardiomyocytes? Am J Physiol Heart Circ Physiol (2005) 1.00
Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop. J Clin Invest (1996) 1.00
Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation. Ann Rheum Dis (2007) 0.99
Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. J Exp Med (1994) 0.99
The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol (1990) 0.99
Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 0.98
T cell triggering by lectins. I. Requirements for interleukin 2 production; lectin concentration determines the accessory cell dependency. Eur J Immunol (1985) 0.97
Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol Int (1989) 0.96
Immunology of DNA. VI. The effect of mercaptans on IgG and IgM anti-dsDNA. J Immunol Methods (1977) 0.96
T cell triggering by lectins. II. Stimuli for induction of interleukin 2 responsiveness and interleukin 2 production differ only in quantitative aspects. Eur J Immunol (1985) 0.96
Mannan binding lectin in febrile adults: no correlation with microbial infection and complement activation. J Clin Pathol (2003) 0.95
Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signals. Eur J Immunol (1992) 0.95
Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodies. J Immunol (1987) 0.95
The role of IL-13 in IgE synthesis by allergic asthma patients. Clin Exp Immunol (1998) 0.95
Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol (1993) 0.95
Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFN-gamma/TNF-alpha and IL-4/IL-5/IL-13, respectively. J Immunol (1998) 0.94
Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes. I. Assay conditions, quantitative aspects and differences between human blood monocytes and neutrophils. Eur J Immunol (1981) 0.94
Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol (1996) 0.91
Effects of smoking on the ex vivo cytokine production in periodontitis. J Periodontal Res (2008) 0.91
Two monoclonal anti-CD3 antibodies can induce different events in human T lymphocyte activation. Eur J Immunol (1987) 0.90
Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants. Biochem J (1996) 0.90
Regulation of IL-12 production by human monocytes and the influence of prostaglandin E2. Ann N Y Acad Sci (1996) 0.90
An improved incubation apparatus for Western blots used for the detection of antinuclear antibodies. J Immunol Methods (1986) 0.90
Immunology of DNA. V. Analysis of DNA/anti-DNA complexes. J Immunol Methods (1976) 0.89
Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3. J Immunol (1987) 0.89
Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? J Autoimmun (1998) 0.88
IgE production in atopic patients is not related to IL-4 production. Clin Exp Immunol (1994) 0.87
Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse. J Rheumatol (1999) 0.87